Loading data
HCATNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 311.14 m USD | 306.58 m USD | 295.94 m USD | 276.24 m USD | 241.93 m USD |
| Research and development expense | 49.77 m USD | 57.95 m USD | 72.63 m USD | 75.68 m USD | 62.73 m USD |
| Operating profit | -160.85 m USD | -69.81 m USD | -126.9 m USD | -140.01 m USD | -143.65 m USD |
| Profit before tax | -177.26 m USD | -69.17 m USD | -117.79 m USD | — | — |
| Income tax expense | 716 k USD | 333 k USD | 356 k USD | -4.3 m USD | -6.9 m USD |
| Net income (reported basis) | -177.97 m USD | -69.5 m USD | -118.15 m USD | -137.4 m USD | -153.21 m USD |
| Net income attributable to common shareholders | -177.97 m USD | -69.5 m USD | -118.15 m USD | -137.4 m USD | -153.21 m USD |
| Basic earnings per share | -2.55 USD/share | -1.15 USD/share | -2.09 USD/share | -2.56 USD/share | -3.23 USD/share |
| Diluted earnings per share | -2.55 USD/share | -1.15 USD/share | -2.09 USD/share | -2.63 USD/share | -3.23 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.